CVE-2017-6707

Description

A vulnerability in the CLI command-parsing code of the Cisco StarOS operating system for Cisco ASR 5000 Series 11.0 through 21.0, 5500 Series, and 5700 Series devices and Cisco Virtualized Packet Core (VPC) Software could allow an authenticated, local attacker to break from the StarOS CLI of an affected system and execute arbitrary shell commands as a Linux root user on the system, aka Command Injection. The vulnerability exists because the affected operating system does not sufficiently sanitize commands before inserting them into Linux shell commands. An attacker could exploit this vulnerability by submitting a crafted CLI command for execution in a Linux shell command as a root user. Cisco Bug IDs: CSCvc69329, CSCvc72930.

Category

8.2
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.22%
Vendor Advisory cisco.com
Affected: n/a Cisco StarOS
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-6707?
CVE-2017-6707 has been scored as a high severity vulnerability.
How to fix CVE-2017-6707?
To fix CVE-2017-6707, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-6707 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-6707 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-6707?
CVE-2017-6707 affects n/a Cisco StarOS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.